More accurate markers identified for detecting response to epigenetic drugs for myelodysplastic syndromes
Sunday, April 7, 2013 - 10:30
in Health & Medicine
Researchers have identified and validated two DNA methylation markers that could help physicians to more accurately determine a patient's response to epigenetic drugs for treatment of myelodysplastic syndromes (MDS), new research suggests.